← ANI PHARMACEUTICALS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Available to Common Stockholders, Basic | $3.9m |
($1.1m)
-127.50%
|
$15.3m
+1525.65%
|
$6.0m
-60.91%
|
($22.5m)
-475.99%
|
($42.8m)
-89.79%
|
($49.5m)
-15.72%
|
$17.2m
+134.64%
|
($20.1m)
-217.45%
|
$77.2m
+483.08%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $3.9m | ($1.1m) | $15.5m | $6.1m | ($22.5m) | ($42.6m) | ($47.9m) | $18.8m | ($18.5m) | $78.3m | — | |
| Depreciation, Depletion and Amortization | $22.3m | $27.9m | $33.7m | $44.6m | $44.6m | $47.3m | $59.7m | $59.8m | $67.7m | $91.4m | $85.8m | |
| Depreciation | $900k | $1.2m | $2.1m | $4.4m | $4.8m | $5.5m | $7.4m | $7.5m | $7.4m | $8.9m | $85.8m | |
| Amortization of Debt Issuance Costs | $844k | $845k | $1.5m | $1.4m | $720k | $914k | $2.4m | $2.4m | — | $0 | — | |
| Amortization of Debt Issuance Costs and Discounts | $7.3m | $7.7m | $8.5m | $7.0m | $1.9m | $2.5m | $4.0m | $3.9m | $642k | $1.4m | — | |
| Amortization of Intangible Assets | $21.4m | $26.7m | $31.7m | $40.2m | $39.9m | $41.8m | $49.5m | $52.3m | $60.3m | $82.5m | — | |
| Deferred Income Tax Expense (Benefit) | ($9.0m) | $3.5m | ($5.4m) | ($7.3m) | ($13.0m) | ($16.9m) | ($15.2m) | ($11.6m) | ($23.0m) | $11.8m | $18.7m | |
| Share-based Payment Arrangement, Noncash Expense | $6.1m | $6.1m | $6.8m | $9.2m | $12.9m | $10.5m | $14.6m | $20.7m | $29.3m | $37.9m | $41.1m | |
| Share-based Payment Arrangement, Expense | $6.1m | $6.0m | $6.7m | $9.1m | $12.8m | $10.4m | $14.3m | — | — | — | $41.1m | |
| Goodwill, Impairment Loss | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $767k | |
| Impairment of Intangible Assets, Finite-lived | $6.7m | $903k | $0 | $75k | $446k | $2.4m | $112k | $0 | $3.6m | $800k | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | — | — | $4.0m | $0 | — | |
| Other Nonoperating Income (Expense) | ($74k) | $55k | ($550k) | ($228k) | ($494k) | ($4.3m) | $670k | ($159k) | ($4.0m) | $1.9m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $24.0m | $12.9m | $4.7m | $7.3m | $23.7m | $5.5m | $36.9m | ($3.4m) | $21.1m | $58.5m | ($48.4m) | |
| Increase (Decrease) in Inventories | $1.9m | ($5.4m) | $379k | $7.7m | $2.8m | ($3.2m) | $23.6m | $5.8m | $21.3m | $6.0m | ($4.6m) | |
| Increase (Decrease) in Accounts Payable | $1.1m | $3k | $3.5m | $5.0m | ($2.3m) | $10.2m | $5.0m | $7.6m | $479k | $15.2m | $10.8m | |
| Gain (Loss) on Disposition of Other Assets | — | — | — | — | — | — | $0 | $0 | $5.3m | ($382k) | — | |
| Net Cash Provided by (Used in) Operating Activities | $27.5m |
$39.4m
+43.49%
|
$67.1m
+70.16%
|
$45.6m
-31.97%
|
$15.3m
-66.54%
|
$3.3m
-78.24%
|
($31.2m)
-1039.28%
|
$119.0m
+481.24%
|
$64.0m
-46.19%
|
$185.2m
+189.34%
|
$189.5m
+2.29%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $4.6m | $10.4m | $5.7m | $6.6m | $6.1m | $2.6m | $8.9m | $8.9m | $16.2m | $13.8m | ($21.9m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($4.6m) | ($10.4m) | ($5.7m) | ($6.6m) | ($6.1m) | ($2.6m) | ($8.9m) | ($8.9m) | $5.3m | ($13.8m) | $382k | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | $16.5m | $0 | $0 | $84.5m | $33k | $0 | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($154.1m) | ($108.0m) | ($27.4m) | ($27.5m) | ($68.3m) | ($105.5m) | ($15.7m) | ($18.5m) | ($404.7m) | ($34.3m) | ($21.9m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | $0 | $0 | ($1.5m) | $0 | $0 | ($7.5m) | $0 | — | |
| Proceeds from Issuance of Long-term Debt | — | $75.0m | $0 | $0 | — | — | — | — | — | — | $0 | |
| Payments for Repurchase of Common Stock | $2.5m | $0 | $0 | — | — | $890k | $2.0m | $5.0m | $11.0m | $12.2m | — | |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | $75.0m | — | $80.6m | $0 | $0 | $0 | |
| Dividends paid | — | — | — | — | — | $190k | $1.6m | $1.6m | $1.6m | $1.2m | ($344k) | |
| Other Interest and Dividend Income | — | — | — | — | — | — | — | — | $6.3m | $4.9m | — | |
| Net Cash Provided by (Used in) Financing Activities | ($729k) |
$72.4m
+10025.51%
|
($27.8m)
-138.44%
|
$1.2m
+104.49%
|
($1.4m)
-215.12%
|
$194.6m
+13622.93%
|
($5.1m)
-102.63%
|
$67.4m
+1415.63%
|
$264.9m
+292.87%
|
($9.9m)
-103.75%
|
($24.6m)
-146.92%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | $0 | $167.9m | ($76.2m) | $140.7m | $360.8m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $36.1m | $48.0m | $67.4m | $12.9m | $105.3m | $53.2m | $221.1m | $144.9m | $285.6m | $360.8m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $0 | $0 | ($470k) | ($233k) | ($554k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $1.6m | $353k | $3.0m | $5.7m | $618k | $2.1m | $1.5m | $9.0m | $6.5m | $13.6m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $4.1m | $3.8m | $6.3m | $6.1m | $6.9m | $9.7m | $21.5m | $31.4m | $24.4m | $26.9m | — | |
| Income Taxes Paid, Net | $9.5m | $17.8m | $6.4m | $10.0m | $5.0m | $10.4m | $288k | $1.2m | $19.1m | $17.7m | — | |
| Additional Financial Items | ||||||||||||
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | — | — | — | $0 | $0 | $6.3m | $2.8m | — | |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | $0 | $0 | ($5.3m) | ($382k) | — | |
| Gain (Loss) on Disposition of Intangible Assets | — | — | — | — | — | $1.8m | $750k | $0 | $0 | $382k | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | ($8.8m) | — | $0 | — | — | — | |
| Goodwill | $1.8m | $1.8m | $3.6m | $3.6m | $3.6m | $27.9m | $28.2m | $28.2m | $60.0m | $62.5m | $767k | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $3.9m | ($1.1m) | $15.5m | $6.1m | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $4.7m | $17.4m | $4.6m | ($2.9m) | ($3.4m) | ($13.5m) | ($14.8m) | $1.1m | ($3.7m) | $17.5m | — |